Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Cancer Consortium (DKTK). For the DKTK partner site Munich, we are seeking for the next possible date a PhD Student in Mutational Processes Driving Somatic Evolution Reference number: 2025-0224 From
-
professor, one assistant professor, one postdoc, and a large number of PhD students. The project includes strong partnerships with the University of Leipzig (Bioinformatics, Prof. Peter Stadler
-
block within this process. You will be embedded both within an experimental and computational team, providing a unique atmosphere where there is expertise to develop the deep-learning models while having
-
://europepmc.org/article/PPR/PPR800886 . Profile Master's in bioinformatics, biomedicine, bioengineering, biotechnology or related fields Interest in linking digital pathology with mechanistic experimental biology
-
experts can reduce the environmental impact of the chemical and agricultural industries, offer eco-friendly analytical techniques, and assess the safety of new materials. The application process in
-
The Institute for Cardiovascular Physiology of Goethe-University has a strong focus on epigenetic processes in the cardiovascular system with emphasis on translation and novel mechanisms. The well
-
of Ultrafast Microscopy and Photonics (Prof. Alexey Chernikov) offers, subject to the availability of resources, a position as Research Associate / PhD Student (m/f/x) (subject to personal qualification
-
computational biology, bioinformatics, systems biology, bioengineering, chemical engineering, or a related discipline Knowledge and experience in the analysis of metagenomics and/or biological high-throughput
-
The overarching goal of the TOBI-team is to enhance precision cancer management through the development of innovative wet-lab and bioinformatic tools for diagnostic, prognostic, and predictive analysis. Prof
-
Company description The Virology, Antiviral & Vaccine Research group at the Rega Institute, led by Prof. Johan Neyts, plays a leading role in the development of innovative antiviral strategies